CRIO’s chief innovation officer, Mike Wenger touches on the two ways sites get AI adoption wrong.
Feature|Articles|February 19, 2026
SCOPE Summit 2026 Wrap Up: Aligning Speed, Strategy, and the Human Element in Clinical Trials
Author(s)Andy Studna, Senior Editor
Across keynotes, panels, and expert interviews, this year’s SCOPE Summit underscored that accelerating clinical research depends on disciplined data strategies, earlier operational planning, and sustained focus on patients, sites, and community trust.
Advertisement
Advertisement
This year’s
Related to this article
CRIO’s Mike Wenger, speaker at this year's SCRS summit, maps how sites are actually deploying AI post-pilot stage.
Paradigm’s Kurt Mussina discusses why scale should drive operational efficiency, not consolidation into single-site studies.
Paradigm’s Kurt Mussina touches on why he rejects the “site management organization” model in favor of one unified business.
ProofPilot’s Lauren Briggs talks on why sponsors and CROs fail at tech rollouts by skipping change management, and pushes for the industry to judge trial technology by real workflow impact rather than feature checklists.
ProofPilot’s Lauren Briggs touches on why site tech adoption hinges on the first 90 days after rollout, and why tools succeed only when they remove work from a site’s plate rather than adding another login to juggle.
Jennifer Byrne, CEO, Javara touches on why fixing clinical research requires sustained infrastructure investment and workforce development.
Sequoia’s Dan White and Dr. Tom Kreamer touch on why sponsors and CROs should treat a site network as one centralized partnerto speed startup timelines and strengthen execution.
Advertisement
Advertisement